feed,title,long_url,short_url
TheStreet,Gilead Remdesivir Output Outlook Draws Analystâ€™s Skepticism,https://www.thestreet.com/investing/gilead-virus-treatment-output-outlook-draws-raymond-james-skepticism,https://j.mp/3fiFyoP
